Current research of RBC alloantibodies associated with blood transfusion and its susceptibility factors
10.13303/j.cjbt.issn.1004-549x.2022.02.028
- VernacularTitle:输血相关红细胞同种抗体及其易感因素的研究现状
- Author:
Yudi XIE
1
;
Li TIAN
1
;
Zhong LIU
1
Author Information
1. Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu 610052, China
- Publication Type:Journal Article
- Keywords:
transfusion-associated;
RBC alloantibody;
susceptibility factor
- From:
Chinese Journal of Blood Transfusion
2022;35(2):233-236
- CountryChina
- Language:Chinese
-
Abstract:
Blood transfusion, an important auxiliary means of clinical treatment, however, is not absolutely safe and risk-free as the transfusion-associated RBC alloantibodies being a potential risk. The yielding rate of RBC alloantibodies in Chinese Han population is about 0.2%, and the researches concerning its production mechanism is particularly critical due to its important clinical significance in patients′ future blood transfusion or pregnancy. This paper reviews the current research status of red blood cell alloantibodies associated with blood transfusion and its susceptibility factors.
